#389 Alpha Score 69.9

Pippa Stevens

Markets and Energy Reporter, CNBC
@PippaStevens13 · tracked since Mar 2026
389
BUZZBERG The leaderboard is ranked by Alpha Score, which weighs a speaker's average return, their number of calls, and reputation — a credibility rating of the source that can only raise a score, never lower it. Read the FAQ
Alpha Score 69.9
Calls
5
Win Rate
80.0%
return
+13.3%
Calls 5 10 Posts tracked · 0.1/day
Calls
7d 0
30d 2
90d 4
Best Calls
MPC Long +36.1%
VLO Long +28.8%
WTI Long +6.2%
Worst Calls
MRNA Long -6.2%
Most Mentioned
VLO ×2
MPC ×2
MRK ×1
Recent Calls
MRK Long 2 weeks ago
MRNA Long 2 weeks ago
MPC Long 1 month ago
Win Rate 80% Long 5 Short 0
Win Rate
7d 80%
30d 100%
90d 100%
Average Return +13.3% Long Return +13.3% Short Return -
Average Return
7d +4.3%
30d +8.6%
90d +4.9%
Loading charts...
Result
Result
Sort
Theme Stance
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Jul 10
$285.25
+36.1%
Refiners benefit from tight capacity and cheap crude.
Refining stocks like Valero and Marathon Petroleum are hitting record highs because gasoline and diesel futures have jumped while crude oil prices fell after 13 million barrels of stranded crude exited the Strait of Hormuz. Limited global spare refining capacity keeps fuel prices elevated, directly benefiting refiners.
Oil & Gas
Long
Jul 10
$284.83
+28.8%
Refiners benefit from tight capacity and cheap crude.
Refining stocks like Valero and Marathon Petroleum are hitting record highs because gasoline and diesel futures have jumped while crude oil prices fell after 13 million barrels of stranded crude exited the Strait of Hormuz. Limited global spare refining capacity keeps fuel prices elevated, directly benefiting refiners.
Oil & Gas
Long
Aug 19
$149.37
+1.7%
Phase 3 melanoma vaccine data beat.
Moderna and Merck's individualized mRNA-based melanoma vaccine combined with Keytruda met both primary and secondary endpoints in a large Phase 3 trial, improving recurrence-free survival and distant metastasis-free survival after surgical removal of melanoma. Moderna shares jumped and Merck shares rose about 7%.
Pharma & Biotech
Long
Aug 19
$160.67
-6.2%
Phase 3 melanoma vaccine data beat.
Moderna and Merck's individualized mRNA-based melanoma vaccine combined with Keytruda met both primary and secondary endpoints in a large Phase 3 trial, improving recurrence-free survival and distant metastasis-free survival after surgical removal of melanoma. Moderna shares jumped and Merck shares rose about 7%.
Pharma & Biotech
Long
Apr 24
$132.92
+6.2%
Oil prices will rise due to supply shortfall.
JPMorgan analysis indicates a large supply shortfall from Strait of Hormuz disruption, requiring demand destruction from the US and Europe, leading to higher oil prices.
Commodities
Showing 5 of 5 calls · sorted by mentions

Pippa Stevens has 5 trade ideas tracked on Buzzberg across 5 tickers since March 2026. Ranked #389 on the Buzzberg Alpha leaderboard. Most covered: VLO, MPC, MRK.